TAC1 and glioblastoma: For example, glioblastoma multiforme cells highly express G protein-coupled receptor neurokinin 1, so a modified substance P as its ligand (213Bi-DOTA-Substance P, where 213Bi is a short-range alpha particle emitter) can be used for targeting neurokinin type 1 receptor-producing cells [36].